Exane BNP Paribas initiated coverage on IDEXX Labs with a new price target
$IDXX
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Health Care
Exane BNP Paribas initiated coverage of IDEXX Labs with a rating of Outperform and set a new price target of $602.00